His research focuses the discovery of new drugs for disorders of neurodevelopment.Dr. Barrow received a B.S. in chemistry from the University of North Carolina at Chapel Hill and a Ph.D. from Harvard University. He then moved to the medicinal chemistry department at Merck Research Laboratories in West Point, working on a variety of drug discovery projects for cardiovascular and central nervous system disorders.Dr. Barrow has authored or co-authored numerous peer-reviewed articles in the field. He currently sits on the Editorial Advisory Board of the journal ACS Chemical Neuroscience.